#EAPM - کشورهای اتحادیه اروپا که از بدترین ضربه برخوردار بودند به عقب برگردند ، در حالی که کارشناسان کنفرانس می خواهند تشخیص بیشتری داشته باشند

| مارس 25، 2020 | 0 نظرات

By خبرنگار بهداشت

Given the circumstances in which we all find ourselves, and the subsequent social distancing, self-isolating and inevitable cancelling of events, EAPM’s virtual conference of yesterday (24 March) was an incredible success, می نویسد:  European Alliance for Personalised Medicine (EAPM) Executive Director Denis Horgan.

No fewer than 18 MEPs were among the hundreds of stakeholder delegates tuning in and contributing. Three of the 18 deputies delivered speeches during the highly informative sessions.

این یک بود marathon conference, taking place throughout the whole روز, and also involved were EMA representatives, plus speakers from the European Commission’s DG SANTE, DG Connect and DG Research. Â

Originally scheduled to be held ⠀ ~زندهâ € ™  in the Belgian capital of Brussels, it was reworked due to the COVID-19 crisis so the event could, nevertheless, take place online.

A swathe of stakeholders and experts came together for the key ‘gathering’, which was entitled ‘Defining the healthcare ecosystem to determine value’. It was EAPM’s 8th annual conference and, this year, was held under the auspices of the Croatia EU Presidency.

How it went…

Those tuning into the lively and interactive sessions represented the multi stakeholder nature that has always characterised the Alliance since its formation – for example patients, scientists, clinicians, researchers, policy makers, key national representatives, journalists and more. Â

One of the key aspects surrounding the invitation of patient speakers was to further our consistent goal of keeping the person in personalised medicine، و همچنین به ensure that the outcome of each session was inclusive, and represented shared decision making. Â

The Alliance would like to take this opportunity to thank all of our سخنرانان، نه کم those doctors and clinicians که took time out from مشغول hospital duties to speak during relevant sessions. How do they do it? We are all in awe… Â

Each session was as interactive as possible and saw panelists asked a key question at the start. This was followed by a poll of ‘attendees’ later.

For example – one question was ‘How should the EU support member states in tackling COVID-19?â € ™

The options were ‘financially’, re-allocation of medical requirement’, ‘setting and ensuring guidelines are followed’, ‘re-allocation of medical staff’, and ‘ensuring essential medicines and diagnostics are developed.’

هشدار اسپویلر: The latter came out on top with 43%.

Asked during the conference whether the EU follow America by giving orphan designation to potential coronavirus drugs,یک European Commissionâ € ™خود Kaja Kantorska said, “we do differ a lotâ €.

To be fair, with some governors Stateside estimating آن some 40–60% of شهروندان could be infected, this begs the question whether that qualifies it as a ‘rare’ disease. Hmm.

Meanwhile during the conference, former DG SANTE official (he’s still an advisor) Antoni Montserrat found a moment to point out that some countries screen infants for a mere two congenital diseases, while others look for up to 42.Â

A regular at EAPM events, Antoni called for a common European framework on the screening of نوزادs.

So many مهم things are happening in Europe and beyond at the moment that, other than the above, we will not give too much detail of the event here, today. But rest assured that a report will follow in the near future…

Beyond the conference…

اروپا leaders are apparently already looking beyond the current crisis and will “start to prepare the measures necessary to get back to a normal functioning of our societies and to sustainable growth, drawing all lessons from the crisisâ €.

This is according to a draft ⠀ œبیانیه مشترکâ€� which is set be agreed during an imminent videoconference.Â

â € œThis will require an exit strategy, a comprehensive recovery plan and unprecedented investment,â €  adds the statement, reports سیاسی.

To continue: “To this end we invite the Commission to start work on a proposal for a Roadmap for recovery accompanied by an Action Planâ €  توسط â € œthe members of the European Councilâ € .Â

Ultimately, this could mean the setting up از â € œa true European Crisis Management Centreâ€� as “the time has come to put into place a more ambitious and wide-ranging crisis management system within the EUâ €.

“The urgency is presently on fighting the Coronavirus pandemic and its immediate consequences,â €  the draft reads. Exactly, and as if they werenâ € ™t busy enough, eh? Nevertheless, this would be a welcome measure.

Meanwhile, the draft continues: “We call on the member states, together with the High Representative and the Commission, to further step up their efforts to ensure that EU citizens stranded in third countries who want to go home can do so.⠀

Testing, testing…

To test or not to test? That is the question. And even if you think that testing is the absolute answer, access to it is all over the place at the moment. Europe’s health officials in Europe, and some citizens are getting grumpy.

Since infected people can spread the virus before symptoms show, more and more Europeans want to get tested. But this is proving difficult, to say the least.

Jean-François Delfraissy، پresident of the French Scientific Coronavirus Committee, believes that massive testing is necessary. As it stands, most EU countries are targeting the most severe cases for testing, as resources are scarce.Â

It has been suggested that a solution could lie with developing antibody tests that can detect whether people have been infected. False negatives are a distinct possibility, yet it could be handy to know down the line how many people were actually infected, even if they didnâ € ™t have symptoms.

Meanwhile, the WHO is working with labs to find out whether those infected who come out of it at the other end relatively unscathed are then protected against the virus,.

Richard Pebody، the WHO Europe Team Lead for High Threat Pathogens, says that such knowledge would gift us with the knowledge of the proportion of the population that is symptomatic, and, by extension, what proportion is infected.Â

The theory is that we could then understand the future course of the epidemic in different populations. ⠀ œWe havenâ € ™t got it yet, but weâ € ™re getting very close,â€� Pebody said.

More negatively, some health experts, however, think we’ve already missed the boat for testing.

â € œWe will not get that disease out of the world anymore,â € Â گفت: Mika Salminen، که استÂ director of health at the Finnish National Institute for Health and Welfare.

Salminen says he understands peopleâ € ™s desire to be tested, نهال those who can ride out the virus at home به دست آوردâ € ™t benefit from it.

â € œThe test is not a cure,â€� he reminded us all.

Nevertheless, suppliers are increasing تولید, although some are reaching capacity and there’s little clue as to how long it would take to increase it. Testing times, indeed…

The lowdown on lockdowns

It seems that most people in ایتالیا،  اسپانیا و  فرانسه support the social distancing ‘lockdown’ measures being employed in their countries to slow down the spread of the virus.

As it stands, these are the three European countries worst-hit by the pandemic in terms of mortality rates, and polls have shown that citizens are more concerned about the impact of the virus on public health than they are about اقتصاد (are you listening دونالد مغلوب ساختن پیشی جستن؟).

An incredible 90% of those in Italy support strict social distancing measures, with 88% of those in Spain backing government rules. France was just a touch behind with 87%. These are huge numbers in favour.

Trial and error?

The WHO has said that small, non-randomized studies of drugs that could work against coronavirus ⠀ œwill not give us the answers we needâ €.

The organization argues that using untested medicines without the right evidence می تواند â € œraise false hopeâ €  and impact on the supplies of essential medicines.

Meanwhile, four drugs that could work against COVID-19Â Â are now involved in a recently begun test in France.

Included are remdesivir; a combination of lopinavir with ritonavir; and another combination of lopinavir, ritonavir and interferon beta. آزمایشی will include 3,200 coronavirus patients from بلژیک،  هلند،  لوکزامبورگ, the UK،  آلمان، France and Spain.Â

Many thanks again to all those who spoke at, and joined in, our virtual conference. Be sure to look out for the upcoming report.

منبع :: خوراک خبرنگار اتحادیه اروپا



دسته بندی: انرژی, دستهبندی نشده

درباره نویسنده ()

پاسخ دهید

آدرس ایمیل شما منتشر نخواهد شد. بخشهای موردنیاز علامتگذاری شدهاند *